Tutkijat / Oulu  | Ala-Kokko, L. |
 | Ala-Kokko, T(ero) |
 | Ala-Korpela, M(ika) |
 | Alahuhta, S. |
 | Alén, M(arkku) |
 | Antikainen, R. |
 | Anttonen, V(uokko) |
 | Biancari, F(austo) |
 | Bloigu, R(isto) |
 | Eskelinen, S. |
 | Flinkkilä, T(apio) |
 | Hakkola, J. |
 | Hallman, M. |
 | Hartikainen, A(nna)-L(iisa) |
 | Hausen, H. |
 | Hautala, N(ina) |
 | Hautala, T(imo) |
 | Heape, A. |
 | Herzig, K(arl)-H(einz) |
 | Hillbom, M. |
 | Hiltunen, J.K. |
 | Hörkko, S. |
 | Huikuri, H(eikki) |
 | Hukkanen J(anne) |
 | Ignatius, J. |
 | Isohanni, M. |
 | Jaakkola, J. |
 | Jaakkola, M(aritta) S. |
 | Jaakola, V-P. |
 | Jämsä, T(imo) |
 | Janhonen, S. |
 | Jartti, T(uomas) |
 | Järvelin, M(arjo)-R(iitta) |
 | Jokelainen, J(ari) |
 | Juffer, A(ndré) H. |
 | Junttila, J(uhani) |
 | Juvonen, T. |
 | Kaarteenaho, R(iitta) |
 | Kajantie, E(ero)*(THL/OY) |
 | Karppinen (Koivunen), P(eppi) |
 | Karppinen, J(aro) |
 | Karttunen, T.J. |
 | Keinänen-Kiukaanniemi, S(irkka) |
 | Kerkelä, R(isto) |
 | Kesäniemi, Y(rjö) A(ntero) |
 | Kettunen, J(ohannes) |
 | Kietzmann, T(homas). |
 | Kivirikko, K.I. |
 | Knuuttila, M. |
 | Koivukangas, J. |
 | Kursula, P(etri) |
 | Kyngäs, H. |
 | Larivaara, P. |
 | Larmas, M. |
 | Lehenkari, P(etri) |
 | Lehtiö, L(ari) |
 | Leppilahti, J. |
 | Luukinen, H. |
 | Mainio A |
 | Majamaa, K. |
 | Mäki, P(irjo) |
 | Mäkikallio, T(imo) H. |
 | Männikkö, M(inna) |
 | Manninen, A(ki). |
 | Martikainen, H(annu) |
 | Miettunen, J(ouko) |
 | Myllyharju, J(ohanna) |
 | Myllylä, R. |
 | Myllylä, V. |
 | Näyhä, S(imo) |
 | Neubauer, P. |
 | Nieminen, M(iika) T. |
 | Nieminen, P(entti) |
 | Niinimäki, J(aakko) |
 | Ohukainen, P(auli) |
 | Oikarinen, A. |
 | Oikarinen, K. |
 | Pelkonen, O(lavi) |
 | Petäjä-Repo, U.E. |
 | Pihlajaniemi, T(aina) |
 | Pirttiniemi, P(ertti) |
 | Puistola, U(lla) |
 | Rajaniemi, H.J. |
 | Räsänen, P. |
 | Raustia, A. |
 | Remes, A(nne) |
 | Risteli, J. |
 | Ristiniemi, J. |
 | Ruddock, L.W. |
 | Ruokonen, A. |
 | Ryynänen, M. |
 | Saarakkala, S. |
 | Saari, A. |
 | Salo, T(uula) |
 | Sándor, G(eorge) K. |
 | Savolainen, E-R. |
 | Savolainen, M.J. |
 | Savolainen, O. |
 | Sillanpää, M(ikko). |
 | Soininen, R. |
 | Sorri, M. |
 | Taanila, A. |
 | Tapiainen, T(erhi) |
 | Tervonen, O(smo) |
 | Timonen, M(arkku) |
 | Turpeenniemi-Hujanen, T. |
 | Tuukkanen, J(uha) |
 | Tuulonen, A. |
 | Uhari, M. |
 | Ukkola, O(lavi) |
 | Uusimaa, J. |
 | Vainio, O. |
 | Vainio, S. |
 | Väyrynen, J(uha) P. |
 | Veijola, J(uha) |
 | Veijola, R(iitta) |
 | Virokannas, H. |
 | Voipio, H(anna)-M(arja) |
 | Vuolteenaho, O. |
 | Weckström, M. |
 | Wei, GH. |
 | Wierenga, R.K. |
 | Winqvist, R(obert) |
 | Ylänne, J. |
 | Ylitalo, K(ari) | Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds |
| | Prognostic impact of impaired left ventricular midwall function during progression of aortic stenosis. | Kesäniemi, Y(rjö) A(ntero) | 75 days | save |  |  |  | |
| Peptide Hormones and Risk for Future Cardiovascular Events among Prediabetics: A 20-Year Follow-Up in the Opera Study. | Kesäniemi, Y(rjö) A(ntero) | 312 days | save |  |  |  | |
| Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study). | Kesäniemi, Y(rjö) A(ntero) | 397 days | save |  |  |  | |
| The validity of hospital discharge register data on non-ST-elevation and ST-elevation myocardial infarction in Finland. | Kesäniemi, Y(rjö) A(ntero) | 436 days | save |  |  |  | |
| Relation of Lipid-Lowering Therapy to Need for Aortic Valve Replacement in Patients With Asymptomatic Mild to Moderate Aortic Stenosis. | Kesäniemi, Y(rjö) A(ntero) | 470 days | save |  |  |  | |
| Non-dipping blood pressure pattern and new-onset diabetes in a 21-year follow-up. | Kesäniemi, Y(rjö) A(ntero) | 613 days | save |  |  |  | |
| Life style habits, biochemical factors and their interaction in the prediction of incident hypertension during 21-year follow-up. | Kesäniemi, Y(rjö) A(ntero) | 783 days | save |  |  |  | |
| Title: Dietary Sodium Intake is Associated with Long-Term Risk of New-Onset Atrial Fibrillation. | Kesäniemi, Y(rjö) A(ntero) | 792 days | save |  |  |  | |
| Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study). | Kesäniemi, Y(rjö) A(ntero) | 835 days | save |  |  |  | |
| Effect of simvastatin and ezetimibe on suPAR levels and outcomes. | Kesäniemi, Y(rjö) A(ntero) | 1024 days | save |  |  |  | |
| Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study. | Kesäniemi, Y(rjö) A(ntero) | 1052 days | save |  |  |  | |
| Increasing ambulatory pulse pressure predicts the development of left ventricular hypertrophy during long-term follow-up. | Kesäniemi, Y(rjö) A(ntero) | 1075 days | save |  |  |  | |
| Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study). | Kesäniemi, Y(rjö) A(ntero) | 1090 days | save |  |  |  | |
| IgA antibodies to phosphocholine associate with long-term cardiovascular disease risk. | Kesäniemi, Y(rjö) A(ntero) | 1118 days | save |  |  |  | |
| Case fatality of acute coronary events is improving even among elderly patients; the FINAMI study 1995-2012. | Kesäniemi, Y(rjö) A(ntero) | 1215 days | save |  |  |  | |
| Ambulatory Pulse Pressure Predicts the Development of Left Ventricular Diastolic Dysfunction in Over 20 Years of Follow-up. | Kesäniemi, Y(rjö) A(ntero) | 1221 days | save |  |  |  | |
| Cardiac Remodeling from Middle Age to Senescence. | Kesäniemi, Y(rjö) A(ntero) | 1316 days | save |  |  |  | |
| A Low-Frequency Inactivating Akt2 Variant Enriched in the Finnish Population is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk. | Kesäniemi, Y(rjö) A(ntero) | 1392 days | save |  |  |  | |
| Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population. | Kesäniemi, Y(rjö) A(ntero) | 1406 days | save |  |  |  | |
| Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention. | Kesäniemi, Y(rjö) A(ntero) | 1422 days | save |  |  |  | |
| Decreased mortality risk due to first acute coronary syndrome in women with postmenopausal hormone therapy use. | Kesäniemi, Y(rjö) A(ntero) | 1531 days | save |  |  |  | |
| SuPAR Predicts Cardiovascular Events and Mortality in Patients With Asymptomatic Aortic Stenosis. | Kesäniemi, Y(rjö) A(ntero) | 1623 days | save |  |  |  | |
| Assessing Optimal Blood Pressure in Patients with Asymptomatic Aortic Valve Stenosis: The SEAS Study. | Kesäniemi, Y(rjö) A(ntero) | 1628 days | save |  |  |  | |
| Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes. | Kesäniemi, Y(rjö) A(ntero) | 1645 days | save |  |  |  | |
| Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study). | Kesäniemi, Y(rjö) A(ntero) | 1890 days | save |  |  |  | |
| Predictors of Development of Echocardiographic Left Ventricular Diastolic Dysfunction in the Subjects Aged 40 to 59 Years (from the Oulu Project Elucidating Risk of Atherosclerosis Study). | Kesäniemi, Y(rjö) A(ntero) | 1962 days | save |  |  |  | |
| Dietary sodium intake and prediction of cardiovascular events. | Kesäniemi, Y(rjö) A(ntero) | 2126 days | save |  |  |  | |
| High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy. | Kesäniemi, Y(rjö) A(ntero) | 2163 days | save |  |  |  | |
| Incidence of Cancer and Mortality in Patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Trial. | Kesäniemi, Y(rjö) A(ntero) | 2302 days | save |  |  |  | |
| High plasma ghrelin protects from coronary heart disease and Leu72Leu polymorphism of ghrelin gene from cancer in healthy adults during the 19 years follow-up study. | Kesäniemi, Y(rjö) A(ntero) | 2306 days | save |  |  |  | |
| Prognostic Significance of Impaired Baroreflex Sensitivity Assessed from Phase IV of the Valsalva Maneuver in a Population-Based Sample of Middle-Aged Subjects. | Kesäniemi, Y(rjö) A(ntero) | 2382 days | save |  |  |  | |
| Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. | Kesäniemi, Y(rjö) A(ntero) | 2495 days | save |  |  |  | |
| Heart Rate Variability Findings as a Predictor of Atrial Fibrillation in Middle-Aged Population. | Kesäniemi, Y(rjö) A(ntero) | 2507 days | save |  |  |  | |
| Circulating cell-free DNA is associated with cardiometabolic risk factors: The Health 2000 Survey. | Kesäniemi, Y(rjö) A(ntero) | 2526 days | save |  |  |  | |
| An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report. | Kesäniemi, Y(rjö) A(ntero) | 2526 days | save |  |  |  | |
| An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia: Executive summary. | Kesäniemi, Y(rjö) A(ntero) | 2547 days | save |  |  |  | |
| An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia. | Kesäniemi, Y(rjö) A(ntero) | 2552 days | save |  |  |  | |
| Leptin Receptor Arg109 Homozygotes Display Decreased Total Mortality as well as Lower Incidence of Cardiovascular Disease and Related Death. | Kesäniemi, Y(rjö) A(ntero) | 2645 days | save |  |  |  | |
| Plasma IgA antibody levels to malondialdehyde acetaldehyde-adducts are associated with inflammatory mediators, obesity and type 2 diabetes. | Kesäniemi, Y(rjö) A(ntero) | 2650 days | save |  |  |  | |
| Long-term fructose feeding changes the expression of leptin receptors and autophagy genes in the adipose tissue and liver of male rats: a possible link to elevated triglycerides. | Kesäniemi, Y(rjö) A(ntero) | 2665 days | save |  |  |  | |
| Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events. | Kesäniemi, Y(rjö) A(ntero) | 2667 days | save |  |  |  | |
| Metabolic syndrome in the prediction of cardiovascular events: The potential additive role of hsCRP and adiponectin. | Kesäniemi, Y(rjö) A(ntero) | 2767 days | save |  |  |  | |
| Peptide hormones in infants with feeding disorders. | Kesäniemi, Y(rjö) A(ntero) | 2806 days | save |  |  |  | |
| Aging of the population may not lead to an increase in the numbers of acute coronary events: a community surveillance study and modelled forecast of the future. | Kesäniemi, Y(rjö) A(ntero) | 2831 days | save |  |  |  | |
| A Blood Pressure Genetic Risk Score Is a Significant Predictor of Incident Cardiovascular Events in 32 669 Individuals. | Kesäniemi, Y(rjö) A(ntero) | 2862 days | save |  |  |  | |
| Target organ damage and masked hypertension in the general population: the Finn-Home study. | Kesäniemi, Y(rjö) A(ntero) | 2874 days | save |  |  |  | |
| Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR<sup>-/-</sup> mice and bind plasma autoantibodies in humans under enhanced carbamylation. | Kesäniemi, Y(rjö) A(ntero) | 2926 days | save |  |  |  | |
| Long telomeres in blood leukocytes are associated with a high risk of ascending aortic aneurysm. | Kesäniemi, Y(rjö) A(ntero) | 2967 days | save |  |  |  | |
| Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk. | Kesäniemi, Y(rjö) A(ntero) | 2982 days | save |  |  |  | |
| Fish consumption, omega-3 fatty acids, and environmental contaminants in relation to low-grade inflammation and early atherosclerosis. | Kesäniemi, Y(rjö) A(ntero) | 3009 days | save |  |  |  | |
|  report | next » | |
|